Russo Edda, Taddei Antonio, Ringressi Maria Novella, Ricci Federica, Amedei Amedeo
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Department of Surgery and Translational Medicine (DCMT), University of Florence, Florence, Italy.
Therap Adv Gastroenterol. 2016 Jul;9(4):594-605. doi: 10.1177/1756283X16635082. Epub 2016 Mar 15.
The data from different studies suggest a bacterial role in cancer genesis/progression, often modulating the local immune response. This is particularly so at the mucosal level where the bacterial presence is strong and the immune system is highly reactive. The epithelial surfaces of the body, such as the skin and mucosa, are colonized by a vast number of microorganisms, which represent the so-called normal microbiome. Normally the microbiome does not cause a proinflammatory response because the immune system has developed different strategies for the tolerance of commensal bacteria, but when these mechanisms are impaired or new pathogenic bacteria are introduced into this balanced system, the immune system reacts to the microbiome and can trigger tumor growth in the intestine. In this review, we discuss the potential role of the bacterial microbiome in carcinogenesis, focusing on the direct and indirect immune adaptive mechanisms, that the bacteria can modulate in different ways.
来自不同研究的数据表明细菌在癌症发生/进展中发挥作用,常对局部免疫反应产生调节作用。在细菌存在量大且免疫系统反应强烈的黏膜水平尤其如此。身体的上皮表面,如皮肤和黏膜,被大量微生物定植,这些微生物构成了所谓的正常微生物群。正常情况下,微生物群不会引发促炎反应,因为免疫系统已形成了耐受共生细菌的不同策略,但当这些机制受损或新的致病细菌被引入这个平衡系统时,免疫系统会对微生物群作出反应,并可能引发肠道肿瘤生长。在本综述中,我们讨论细菌微生物群在致癌作用中的潜在作用,重点关注细菌能够以不同方式调节的直接和间接免疫适应性机制。